Ben Beneski

Observer
DISC Type : ci

Chief Technical Officer (CTO) at Allogene Therapeutics

San Francisco, California, United States

Overview

Ben Beneski is the Chief Technical Officer at Allogene Therapeutics, leveraging over two decades of experience in biologics manufacturing from roles at Amgen and Vir Biotechnology. Educated at Stevens Institute of Technology and Northeastern, he focuses on advancing the companys pioneering allogeneic cell therapy programs through technical and operational leadership.

Outside of work, Ben is passionate about connecting his team to the community they serve. He leads and participates in volunteer activities, such as serving dinner at Family House, to create a direct and meaningful connection with patients and their families, reinforcing the human impact of their scientific work.

Ben led the design, construction, and startup of Cell Forge 1, Allogenes state-of-the-art cell therapy manufacturing facility.

Personality Overview

Value Driven

Example Seeker

Assertive

They are generally strong communicators and are not easy to convince.  They can sound friendly and charming but can quickly change gears to become inquisitive and probing. They are likely to ask many questions and look heavily for supporting information.

Topics They Care About

Cell Therapy Manufacturing
He is a frequent speaker on advancing cell therapy manufacturing and is focused on solving challenges to achieve commercial viability and greater scale.
Biomanufacturing Innovation
As CTO with deep experience in CMC operations, he is focused on creating innovative solutions and next-generation platforms for biomanufacturing.
Technical Operations
His career has been centered on technical operations, including process development, tech transfer, and managing both internal and external manufacturing networks.

Media Appearances

Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief .... Featured in Allogene Therapeutics Investor Relations

See Now

Work History

3-2025
Chief Technical Officer (CTO) at Allogene Therapeutics
5-2024 - 3-2025
Vice President, Product Development and Manufacturing at Allogene Therapeutics
2-2022 - 5-2024
Vice President, Manufacturing at Allogene Therapeutics
5-2018 - 5-2019
Sr. Director, CMC Lifecycle Operations at Vir Biotechnology, Inc.
11-2013 - 5-2018
Director Global Operations at Amgen

Education

2001 - 2003
MBA from D'Amore-McKim School of Business at Northeastern University
1994 - 1998
BE from Stevens Institute of Technology

More Information

Social Presence :

Prographics :

Exp : 16 Location : San Francisco, California, United States Job Level : Leadership Designation : Chief Technical Officer (CTO) at Allogene Therapeutics
URL has been copied!

Insights For Selling To Ben

During A Call Or A Meeting

DO's

  • Persuade objectively how your product will help them achieve their goals
  • Build rapport, it will come handy to handle hard questions later
  • Share testimonials from known people and give multiple examples of product value

DONT's

  • Avoid making offhand commitments
  • Don’t try to rush them into a decision, provide all necessary information first
  • Don’t rely excessively on your relationship with them to win the deal

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Ben is

  • Proven value, strong testimonials are important to them, relationships will have some weightage.
  • Will you ever get a clear answer from Ben

  • They are practical yet friendly, don’t expect a clear no very often.

Insights For Deal Planning

    How fast (or slow) will Ben move?

  • They like to analyze well and then make their decisions.
  • Can Ben take some risk or not?

  • They evaluate their decisions systematically and are less likely to take risks.

You And Ben

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.